Jun 02, 2012 - SAN DIEGO (MedPage Today) -- Many patients with early signs of multiple sclerosis go to an emergency room for care, but, at one big-city hospital, the diagnosis was initially missed in nearly 40% of cases. (Source: MedPage Today Neurology)

Jun 02, 2012 - WASHINGTON (MedPage Today) -- The FDA has warned consumers against using a Mexican "natural? dietary supplement promoted for pain relief due to unlabeled, potentially harmful ingredients. (Source: MedPage Today Endocrinology)

Jun 02, 2012 - The recent suicide of Mary Kennedy tracks to the long, sorry history of addiction and depression among prominent political wives, and shows how little our popular treatments have to offer them.read more (Source: Psychology Today Addiction Center)

Jun 02, 2012 - Although research conducted in a large UK study failed to prove cannabis effective for slowing the progression of Multiple Sclerosis (MS), patients reported marijuana helpful for relieving symptoms of...(PRWeb June 02, 2012)Read the full story at http://www.prweb.com/releases/-medical-marijuana/-information-san-francisc/prweb9568927.htm (Source: PRWeb: Medical Pharmaceuticals)

Jun 02, 2012 - NEW YORK, June 2, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced completion of enrollment of the PICASSO 3 trial, an international, randomized, double-blind, placebo-controlled Phase 3 clinical study of palifosfamide in combination with doxorubicin, versus doxorubicin alone, for the treatment of metastatic soft tissue sarcoma (STS) in the front-line setting. Doxorubicin is the current standard of care for the treatment of STS in the front-line setting. (Source: Medical News (via PRIMEZONE))

Jun 02, 2012 - (Source: Molecular Diagnosis)